Scarica l'app Stockscreener
3.22
7.69%
0.23
Dopo l'orario di chiusura:
3.15
-0.07
-2.17%
Precedente Chiudi:
$2.99
Aprire:
$2.93
Volume 24 ore:
37,528
Relative Volume:
0.39
Capitalizzazione di mercato:
$12.63M
Reddito:
$125.00K
Utile/perdita netta:
$-14.50M
Rapporto P/E:
-0.6993
EPS:
-4.6043
Flusso di cassa netto:
$-14.18M
1 W Prestazione:
+18.82%
1M Prestazione:
-2.13%
6M Prestazione:
-40.81%
1 anno Prestazione:
-76.49%
Intervallo 1D:
$2.85
$3.24
Intervallo di 1 settimana:
$2.6204
$3.24
Portata 52W:
$2.52
$41.22
Imunon Inc Stock (IMNN) Company Profile
Nome
Imunon Inc
Settore
Industria
Telefono
(609) 896-9100
Indirizzo
997 LENOX DRIVE, LAWRENCEVILLE
Compare IMNN vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IMNN
Imunon Inc
|
3.22 | 12.63M | 125.00K | -14.50M | -14.18M | -4.6043 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Imunon Inc Borsa (IMNN) Ultime notizie
Imunon Earnings Call: Strong Data, Tight Cash Runway - tipranks.com
Imunon, Inc. (NASDAQ:IMNN) Q4 2025 Earnings Call Transcript - Insider Monkey
IMNN Technical Analysis & Stock Price Forecast - Intellectia AI
Imunon Q4 Earnings Call Highlights - Defense World
IMNN PE Ratio & Valuation, Is IMNN Overvalued - Intellectia AI
Imunon, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
IMUNON reports final Phase 2 data for ovarian cancer treatment By Investing.com - Investing.com South Africa
Imunon targets ~80 OVATION 3 patients in the next 12 months as cash runway extends into H2 2026 - MSN
Imunon Inc (IMNN) Q4 2025 Earnings Call Highlights: Strategic Ad - GuruFocus
IMUNON 2025 Financial Review - AlphaStreet
IMUNON Reports 2025 Financial Results and Highlights Breakthrough Phase 3 Progress for IMNN-001 in Advanced Ovarian Cancer - Minichart
Imunon Inc’s 2025 Q4 Earnings Call: FDA Submission Delays, Shifting Trial Timelines, and Enrollment Discrepancies Highlight Contradictions - Bitget
IMUNON INC (NASDAQ:IMNN) Reports Q4 2025 Results with Focus on Phase 3 Progress for IMNN-001 - ChartMill
Earnings call transcript: Imunon Inc’s Q4 2025 shows cost discipline, clinical progress - Investing.com
IMUNON ($IMNN) Releases Q4 2025 Earnings - Quiver Quantitative
IMUNON, INC. 2025 Annual Report: Pipeline, Clinical Trials, Financials & Business Strategy Overview - Minichart
Imunon (NASDAQ: IMNN) posts strong IMNN-001 survival data but flags going concern risk - Stock Titan
Imunon Reports 2025 Financial Results And Provides Business Update - TradingView
Imunon reports $14.5M net loss and $8.8M cash at year-end; highlights Phase 3 progress - TradingView
Imunon, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
IMUNON (IMNN) highlights 2025 loss reduction and strong IMNN-001 survival data - Stock Titan
IMUNON says ovarian cancer therapy added 14.7 months survival - Stock Titan
IMUNON reports final Phase 2 data for ovarian cancer treatment - Investing.com
Imunon Scheduled to Announce Q4 Earnings on March 30 - Intellectia AI
Inflation Data: Can Imunon Inc sustain earnings growthPortfolio Profit Report & Verified Technical Trade Signals - baoquankhu1.vn
IMUNON reports improved survival data for ovarian cancer therapy By Investing.com - Investing.com South Africa
Imunon Inc. Expands Market Footprint Amid Strategic Deals and Financial Challenges - timothysykes.com
IMUNON's IMNN-001 Shows Continued Gains In Overall Survival In Phase 2 Ovarian Cancer Trial - RTTNews
Imunon (IMNN) Reports Promising Phase 2 OVATION 2 Trial Results - GuruFocus
IMUNON reports improved survival data for ovarian cancer therapy - investing.com
With PARP therapy, women on IMUNON lived 24.2 months longer - stocktitan.net
Guidance Update: Can Imunon Inc reach all time highs this yearJobs Report & Safe Capital Investment Plans - baoquankhu1.vn
Aug Closing: Is Imunon Inc stock a good pick for beginners2026 Big Picture & Real-Time Volume Analysis Alerts - baoquankhu1.vn
IMUNON to Hold 2025 Financial Results and Business Update Conference Call on Tuesday, March 31, 2026 - marketscreener.com
IMUNON, Inc. Files Form 8-K with NASDAQ Listing and Company Details for March 2026 - Minichart
Imunon registers additional $7 million in shares under at-the-market offering - Investing.com India
Imunon Expands At-The-Market Equity Offering Capacity - TipRanks
Imunon registers additional $7M, raising ATM capacity to $17M - TradingView
Imunon (NASDAQ: IMNN) boosts at-the-market stock program to $17M - Stock Titan
Imunon (NASDAQ: IMNN) ups ATM program by $7M to $17M capacity - Stock Titan
S P Trends: What is the next catalyst for Imunon Inc2026 Weekly Recap & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Dividend Watch: Will Imunon Inc outperform tech stocksQuarterly Profit Report & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Imunon Q2 2025 Earnings Preview - MSN
Imunon declares $0.15 dividend - MSN
Signal Recap: Will Imunon Inc outperform tech stocksGold Moves & Low Risk Entry Point Guides - baoquankhu1.vn
Market Overview: Is Imunon Inc a defensive stock2025 Key Highlights & Smart Swing Trading Techniques - baoquankhu1.vn
IMNN Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
IMNN SEC FilingsImunon Inc 10-K, 10-Q, 8-K Forms - Stock Titan
IMNN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Imunon Inc expected to post a loss of $1.17 a shareEarnings Preview - TradingView
What risks investors should watch in Imunon Inc. stockWeekly Profit Report & Risk Controlled Swing Alerts - mfd.ru
Imunon Inc Azioni (IMNN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):